<div _ngcontent-ng-c2377978868="" id="version-content-panel" class="content-panel"><ctg-section-title-card _ngcontent-ng-c2377978868="" id="study-details-card" title="Study Details" ctgintersectionobserver="" _nghost-ng-c884230767="">Study Details
</ctg-section-title-card><ctg-study-identification _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="study-id-card" _nghost-ng-c533340368=""><ctg-study-section-compare-card _ngcontent-ng-c533340368="" title="Study Identification" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Study Identification </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Unique Protocol ID</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">RDX-002-024-011</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Brief Title</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Official Title</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of RDX-002 on Postprandial Triglycerides in Patients Discontinuing the Glucagon-like Peptide-1 (GLP-1) Agonists, Semaglutide or Tirzepatide, for the Treatment of Obesity</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Secondary IDs</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell"></div><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card></ctg-study-identification><!----><ctg-study-status _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="study-status-card" _nghost-ng-c2969485090=""><ctg-study-section-compare-card _ngcontent-ng-c2969485090="" title="Study Status" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Study Status </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Record Verification</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2025-<span class="ctg-diff-removed">02</span><span class="ctg-diff-added">12</span></div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Overall Status</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c2969485090=""><ctg-enum-value _ngcontent-ng-c2969485090="" renderside="left" path="protocolSection.statusModule.overallStatus" _nghost-ng-c4292062698=""><!----><!----><span _ngcontent-ng-c4292062698="" class="ctg-diff-removed">Active, not recruiting</span><!----><span _ngcontent-ng-c4292062698="" class="ctg-diff-added">Completed</span><!----><!----><!----><!----><!----><!----></ctg-enum-value><!----><!----></div><!----><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Study Start</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2024-09-27 [Actual]</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Primary Completion</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2025-01-04 [Actual]</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Study Completion</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2025-<span class="ctg-diff-removed">04</span><span class="ctg-diff-added">05-13</span> [<span class="ctg-diff-removed">Estimated</span><span class="ctg-diff-added">Actual</span>]</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">First Submitted</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2024-10-08</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">First Submitted that Met QC Criteria</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2024-10-10</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">First Posted</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2024-10-15 [Actual]</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Last Update Submitted that Met QC Criteria</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2025-<span class="ctg-diff-removed">02</span><span class="ctg-diff-added">12</span>-<span class="ctg-diff-removed">04</span><span class="ctg-diff-added">22</span></div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Last Update Posted</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2025-<span class="ctg-diff-removed">02</span><span class="ctg-diff-added">12</span>-<span class="ctg-diff-removed">07</span><span class="ctg-diff-added">23</span> [<span class="ctg-diff-removed">Actual</span><span class="ctg-diff-added">Estimated</span>]</div><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----></ctg-study-status><!----><ctg-sponsor-collaborators-card _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="sponsor-collaborators-card" _nghost-ng-c711903603=""><ctg-study-section-compare-card _ngcontent-ng-c711903603="" title="Sponsor/Collaborators" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Sponsor/Collaborators </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Sponsor</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><span _ngcontent-ng-c711903603="">Response Pharmaceuticals</span><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Responsible Party</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><span _ngcontent-ng-c711903603=""><ctg-enum-value _ngcontent-ng-c711903603="" path="protocolSection.sponsorCollaboratorsModule.responsibleParty.type" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Sponsor</span><!----><!----><!----></ctg-enum-value></span><!----><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Collaborators</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----><!----></ctg-sponsor-collaborators-card><!----><ctg-oversight _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="oversight-card" _nghost-ng-c2845012368=""><ctg-study-section-compare-card _ngcontent-ng-c2845012368="" title="Oversight" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Oversight </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">U.S. FDA-regulated Drug</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c2845012368=""><ctg-boolean-value-compare _ngcontent-ng-c2845012368="" _nghost-ng-c3941119268=""><span _ngcontent-ng-c3941119268="">Yes</span></ctg-boolean-value-compare></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">U.S. FDA-regulated Device</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c2845012368=""><ctg-boolean-value-compare _ngcontent-ng-c2845012368="" _nghost-ng-c3941119268=""><span _ngcontent-ng-c3941119268="">No</span></ctg-boolean-value-compare></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Data Monitoring</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c2845012368=""><ctg-boolean-value-compare _ngcontent-ng-c2845012368="" _nghost-ng-c3941119268=""><span _ngcontent-ng-c3941119268="">No</span></ctg-boolean-value-compare></div><!----><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----><!----><!----><!----><!----></ctg-oversight><!----><!----><ctg-study-description _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="study-description-card" _nghost-ng-c2240099824=""><ctg-study-section-compare-card _ngcontent-ng-c2240099824="" title="Study Description" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Study Description </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Brief Summary</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell"><p>The goal of this clinical trial is to learn if drug RDX-002 works to treat high levels of fat (known as triglycerides, or TGs) in the blood in adults.
It will also learn about the safety of drug RDX-002.
The main question it aims to answer is if treatment with RDX-002 will lower triglycerides after a high-fat meal in patients who have recently stopped treatment with semaglutide or tirzepatide for obesity.
The trial will also examine the effect of RDX-002 on body weight and fasting levels of cholesterol.</p><p>Researchers will compare RDX-002 to a placebo (a look-alike substance that contains no drug) to see if RDX-002 works to reduce triglycerides.</p><p>Participants will:</p><p>Take drug RDX-002 or a placebo every day for 12 weeks Visit the clinic once every 4 weeks for checkups and tests</p></div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Detailed Description</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell"><p>This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group study that will be conducted at a single study site in the United States (US).</p><p>Patients who have planned discontinuation of semaglutide or tirzepatide treatment for obesity, have lost ≥10% or 10 Killigrams (kg) of their original body weight and are aged 18 to 65 years will be eligible for Screening.
The study will assess the efficacy of 12 weeks of treatment with 200 mg twice daily (BID) RDX-002 or placebo on the mean percentage change from baseline on postprandial TGs among patients who have recently discontinued treatment with semaglutide or tirzepatide for obesity.
The trial will also examine the impact of RDX-002 on body weight and fasting levels of cholesterol.</p></div><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card></ctg-study-description><!----><ctg-study-condition _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="conditions-card" _nghost-ng-c570131710=""><ctg-study-section-compare-card _ngcontent-ng-c570131710="" title="Conditions" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Conditions </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Condition</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c570131710=""><div _ngcontent-ng-c570131710="">Triglycerides</div><div _ngcontent-ng-c570131710="">Weight Gain Trajectory</div><div _ngcontent-ng-c570131710="">Cholesterol, Elevated</div><!----></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Keywords</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c570131710=""><div _ngcontent-ng-c570131710="">RDX-002</div><div _ngcontent-ng-c570131710="">GLP1</div><div _ngcontent-ng-c570131710="">triglyceride</div><div _ngcontent-ng-c570131710="">obesity</div><div _ngcontent-ng-c570131710="">semaglutide</div><div _ngcontent-ng-c570131710="">tirzepatide</div><div _ngcontent-ng-c570131710="">microsomal triglyceride transfer protein inhibitor</div><div _ngcontent-ng-c570131710="">MTP</div><!----></div><!----><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----></ctg-study-condition><!----><ctg-study-design _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="study-design-card" _nghost-ng-c4246597087=""><ctg-study-section-compare-card _ngcontent-ng-c4246597087="" title="Study Design" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Study Design </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Study Type</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c4246597087=""><ctg-enum-value _ngcontent-ng-c4246597087="" path="protocolSection.designModule.studyType" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Interventional</span><!----><!----><!----></ctg-enum-value><!----></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Primary Purpose</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c4246597087=""><ctg-enum-value _ngcontent-ng-c4246597087="" path="protocolSection.designModule.designInfo.primaryPurpose" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Prevention</span><!----><!----><!----></ctg-enum-value></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Study Phase</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c4246597087=""><div _ngcontent-ng-c4246597087=""><ctg-enum-value _ngcontent-ng-c4246597087="" path="protocolSection.designModule.phases" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Phase 2</span><!----><!----><!----></ctg-enum-value></div><!----></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Interventional Study Model</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c4246597087=""><ctg-enum-value _ngcontent-ng-c4246597087="" path="protocolSection.designModule.designInfo.interventionModel" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Parallel Assignment</span><!----><!----><!----></ctg-enum-value></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Number of Arms</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">2</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Masking</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c4246597087=""><ctg-enum-value _ngcontent-ng-c4246597087="" path="protocolSection.designModule.designInfo.maskingInfo.masking" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Triple</span><!----><!----><!----></ctg-enum-value> (<span _ngcontent-ng-c4246597087="">Participant, Care Provider, Investigator</span>) <!----></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Masking Description</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">Sponsor</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Allocation</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c4246597087=""><ctg-enum-value _ngcontent-ng-c4246597087="" path="protocolSection.designModule.designInfo.allocation" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Randomized</span><!----><!----><!----></ctg-enum-value></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Enrollment</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">68 [Actual]</div><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----><!----><!----><!----><!----><!----><!----><!----></ctg-study-design><!----><ctg-arms-interventions-card _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="arms-and-interventions-card" _nghost-ng-c3380698692=""><ctg-card _ngcontent-ng-c3380698692="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Arms and Interventions </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3380698692="" style="overflow-x: auto;" class="table"><div _ngcontent-ng-c3380698692="" class="cell title-cell"><span _ngcontent-ng-c3380698692="">Arms</span></div><!----><div _ngcontent-ng-c3380698692="" class="cell title-cell"><span _ngcontent-ng-c3380698692="">Assigned Interventions</span></div><div _ngcontent-ng-c3380698692="" class="cell content-cell text-cell"><ctg-arm-group-widget _ngcontent-ng-c3380698692="" _nghost-ng-c2447741841=""><span _ngcontent-ng-c2447741841="">Experimental: Investigational drug</span><div _ngcontent-ng-c2447741841="" class="description">The effect of 12 weeks of treatment with RDX-002 on postprandial TGs, fasting levels of cholesterol, and body weight among patients who have recently discontinued treatment with the GLP-1 agonists, semaglutide or tirzepatide, for obesity.</div><!----><!----></ctg-arm-group-widget><!----><!----></div><!----><div _ngcontent-ng-c3380698692="" class="cell content-cell text-cell interventions-cell"><ctg-intervention-widget _ngcontent-ng-c3380698692="" _nghost-ng-c1595763969=""><span _ngcontent-ng-c1595763969="">Drug: RDX-002</span><ul _ngcontent-ng-c1595763969="" class="list-content"><li _ngcontent-ng-c1595763969=""><p _ngcontent-ng-c1595763969="">Gut-specific microsomal triglyceride transfer protein (MTP) inhibitor</p></li><!----><!----></ul><!----></ctg-intervention-widget><!----><!----><!----></div><div _ngcontent-ng-c3380698692="" class="cell content-cell text-cell"><ctg-arm-group-widget _ngcontent-ng-c3380698692="" _nghost-ng-c2447741841=""><span _ngcontent-ng-c2447741841="">Placebo Comparator: Placebo</span><div _ngcontent-ng-c2447741841="" class="description">Matching placebo</div><!----><!----></ctg-arm-group-widget><!----><!----></div><!----><div _ngcontent-ng-c3380698692="" class="cell content-cell text-cell interventions-cell"><ctg-intervention-widget _ngcontent-ng-c3380698692="" _nghost-ng-c1595763969=""><span _ngcontent-ng-c1595763969="">Drug: Placebo</span><ul _ngcontent-ng-c1595763969="" class="list-content"><li _ngcontent-ng-c1595763969=""><p _ngcontent-ng-c1595763969="">Matching placebo</p></li><!----><!----></ul><!----></ctg-intervention-widget><!----><!----><!----></div><!----></div><!----></div></ctg-card></ctg-arms-interventions-card><!----><ctg-protocol-outcome-measures _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="outcome-measures-card" _nghost-ng-c817611053=""><ctg-study-section-compare-card _ngcontent-ng-c817611053="" title="Outcome Measures" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Outcome Measures </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Primary Outcome Measures</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958=""><ol _ngcontent-ng-c817611053=""><li _ngcontent-ng-c817611053=""><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="measure" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Triglycerides</span></ctg-diff-value-renderer></div><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="description" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Difference in the mean percent change in the incremental postprandial TG area under the curve (AUC) in patients treated with RDX 002 as compared with placebo at Week 12.</span></ctg-diff-value-renderer></div><!----><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer2 _ngcontent-ng-c817611053="" _nghost-ng-c3749385431=""><span _ngcontent-ng-c3749385431="">[Time Frame: 12 weeks]</span></ctg-diff-value-renderer2></div><!----><!----></li><!----><!----><!----></ol><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Secondary Outcome Measures</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958=""><ol _ngcontent-ng-c817611053=""><li _ngcontent-ng-c817611053=""><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="measure" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Change in mean percent body weight</span></ctg-diff-value-renderer></div><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="description" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Difference in the mean percent change from baseline in body weight in patients treated with RDX-002 as compared with placebo at Week 12.</span></ctg-diff-value-renderer></div><!----><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer2 _ngcontent-ng-c817611053="" _nghost-ng-c3749385431=""><span _ngcontent-ng-c3749385431="">[Time Frame: 12 weeks]</span></ctg-diff-value-renderer2></div><!----><!----></li><!----><!----><li _ngcontent-ng-c817611053=""><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="measure" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">LDL-C</span></ctg-diff-value-renderer></div><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="description" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Difference in the mean percent change from baseline in LDL-C in patients treated with RDX-002 as compared with placebo at week 12.</span></ctg-diff-value-renderer></div><!----><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer2 _ngcontent-ng-c817611053="" _nghost-ng-c3749385431=""><span _ngcontent-ng-c3749385431="">[Time Frame: 12 weeks]</span></ctg-diff-value-renderer2></div><!----><!----></li><!----><!----><li _ngcontent-ng-c817611053=""><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="measure" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Change in body weight by 5%</span></ctg-diff-value-renderer></div><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer _ngcontent-ng-c817611053="" property="description" _nghost-ng-c1563154733=""><span _ngcontent-ng-c1563154733="">Difference in the proportion of patients treated with RDX-002 exhibiting at least a 5% increase from baseline in body weight as compared with placebo at Week 12.</span></ctg-diff-value-renderer></div><!----><div _ngcontent-ng-c817611053="" class="value-list"><ctg-diff-value-renderer2 _ngcontent-ng-c817611053="" _nghost-ng-c3749385431=""><span _ngcontent-ng-c3749385431="">[Time Frame: 12 Weeks]</span></ctg-diff-value-renderer2></div><!----><!----></li><!----><!----><!----></ol><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----></ctg-protocol-outcome-measures><!----><!----><ctg-eligibility _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="eligibility-card" _nghost-ng-c413105209=""><ctg-study-section-compare-card _ngcontent-ng-c413105209="" title="Eligibility" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Eligibility </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Minimum Age</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">18 Years</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Maximum Age</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell">65 Years</div><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Sex</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c413105209=""><ctg-enum-value _ngcontent-ng-c413105209="" path="protocolSection.eligibilityModule.sex" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">All</span><!----><!----><!----></ctg-enum-value></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Gender-based Eligibility</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Gender Eligibility Description</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Accepts Healthy Volunteers</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><div _ngcontent-ng-c413105209=""><ctg-boolean-value-compare _ngcontent-ng-c413105209="" _nghost-ng-c3941119268=""><span _ngcontent-ng-c3941119268="">No</span></ctg-boolean-value-compare></div><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Criteria</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><!----><div _ngcontent-ng-c1323710958="" class="text-cell"><p>Inclusion Criteria:</p><ol><li>Willing and able to provide written informed consent prior to the conduct of any study specific procedures;</li><li>Planned or willing discontinuation of semaglutide or tirzepatide for the treatment of obesity prior to randomization (Visit T1/Day 1) through the end of study (EOS);</li><li>Lost ≥10% or 10 kg of original (pre-GLP-1 baseline) body weight with semaglutide or tirzepatide;</li><li>Males and females aged 18 to 65 years (both inclusive) at Screening (Visit S1);</li><li>A hemoglobin A1C (HbA1c) of &lt;6.5% at Screening (Visit S1);</li><li>A 12-lead (electrocardiograph) ECG at Screening (Visit S1) which, in the opinion of the investigator, had no abnormalities that compromised safety in this study;</li><li>Males and nonpregnant, nonlactating females.
Females must be either of non-childbearing potential or use appropriate birth control methods and have a negative pregnancy test at Screening</li></ol><p>Exclusion Criteria:</p><ol><li>Type 1 or Type 2 diabetes;</li><li>Recent (within 3 months prior to the Screening visit [Visit S1]) cardiovascular event or planned or recent cardiovascular surgery or intervention.
Patients with implantable pacemakers or automatic implantable cardioverter defibrillators may be considered if deemed by the investigator to be stable for the previous 3 months;</li><li>Uncontrolled hypertension, defined as systolic blood pressure (SBP) &gt;160 mmHg and diastolic blood pressure (DBP) &gt;100 millimeters of mercury (mmHg) after being in supine position for 5 minutes;</li><li>Total fasting (minimum of 10 hours) TGs ≥400 milligrams per deciliter (mg/dL) (4.5 millimoles per liter (mmol/L)) at Screening (Visit S1);</li><li>Fasting glucose &gt;126 mg/dL at Screening (Visit S1);</li><li>Uncontrolled hypothyroidism, including thyroid stimulating hormone (TSH) &gt;1.5 × the upper limit of normal (ULN) at Screening (Visit S1); patients stabilized on thyroid replacement therapy for at least 6 weeks prior to randomization (Visit T1/Day 1) are allowed; Liver disease or dysfunction, including positive serology or hepatitis B and/or C or significant elevations in certain liver function tests</li><li>Renal dysfunction or glomerulonephritis, including estimated glomerular filtration rate (eGFR; using the Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] 2021 formula) &lt;60 milliliters per minute (mL/min) at Screening (Visit S1).</li><li>Gastrointestinal conditions or procedures (including weight loss surgery; e.g., Lap-Band® or gastric bypass) except uncomplicated cholecystectomy and appendectomy that may affect drug absorption;</li><li>Known history of hematologic or coagulation disorders or a hemoglobin level &lt;10.0 grams/deciliter (g/dL) at Screening (Visit S1);</li><li>Active malignancy, including those requiring surgery, chemotherapy, and/or radiation in the past 5 years.
Nonmetastatic basal or squamous cell carcinoma of the skin and cervical carcinoma in situ are allowed;</li><li>Unexplained creatine kinase (CK) &gt;3 × ULN at any time prior to randomization (i.e., not associated with recent trauma or physically strenuous activity).
Patients with an explained CK elevation must have single repeat CK ≤3 × ULN prior to randomization;</li><li>History of drug or alcohol abuse within the last 2 years or reported current consumption of &gt;14 alcoholic drinks/week, or any illicit drug use (checked positive for standard drug screening panel).
Patients testing positive for tetrahydrocannabinol (THC) (whether prescribed or not) and for amphetamine derivatives prescribed by and under the care of a health care practitioner (except for weight management) can be enrolled after evaluation and at the discretion of the investigator;</li><li>Inability to follow the required minimum 2 meals a day, or unwillingness to consume meal on both study test occasions, or inability to fast, as required during the study;</li><li>Blood donation, participation in multiple blood draws, clinical study, major trauma, blood transfusion or surgery with or without blood loss within 30 days prior to randomization (Visit T1/Day 1);</li><li>Use of any experimental or investigational drugs except GLP-1 agonists within 30 days or 5 half-lives (whichever is longer) prior to Screening (Visit S1);</li><li>Use of any prohibited diabetes or other weight loss drugs prior to or during the study (as specified) unless meeting specific rescue criteria:</li><li>Recent (within 30 days unless otherwise specified) initiation or discontinuation of lipid-lowering medications.
Consistent background use is allowed;</li><li>An employee or contractor of the facility conducting the study, or a family member of the principal investigator, co-investigator, or any Sponsor personnel;</li><li>Pregnant, breastfeeding, or intending to become pregnant within 30 days after study completion or last dose of study drug;</li><li>A medical or situational (i.e., geographical) finding that, in the investigator's opinion, may compromise the patient's safety or ability to complete the study.</li></ol></div><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----><!----><!----><!----><!----></ctg-eligibility><!----><ctg-contacts-locations-card _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="contacts-locations-card" _nghost-ng-c2610029805=""><ctg-study-section-compare-card _ngcontent-ng-c2610029805="" title="Contacts/Locations" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Contacts/Locations </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Central Contact Person</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Study Officials</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><ul _ngcontent-ng-c2610029805="" class="ul-adjust-margin"><li _ngcontent-ng-c2610029805=""><ctg-overall-officials-item _ngcontent-ng-c2610029805="" _nghost-ng-c3494358620=""><div _ngcontent-ng-c3494358620="" class="details"><div _ngcontent-ng-c3494358620="" class="details-title-indent">Name</div><div _ngcontent-ng-c3494358620="" class="details-value-less"><span _ngcontent-ng-c3494358620="">Trisha Stamp, PhD, PA-C</span></div></div><div _ngcontent-ng-c3494358620="" class="details"><div _ngcontent-ng-c3494358620="" class="details-title-indent">Role</div><div _ngcontent-ng-c3494358620="" class="details-value-less"><span _ngcontent-ng-c3494358620=""><ctg-enum-value _ngcontent-ng-c3494358620="" path="protocolSection.contactsLocationsModule.overallOfficials.role" _nghost-ng-c4292062698=""><!----><span _ngcontent-ng-c4292062698="">Principal Investigator</span><!----><!----><!----></ctg-enum-value><!----><!----></span></div></div><div _ngcontent-ng-c3494358620="" class="details"><div _ngcontent-ng-c3494358620="" class="details-title-indent">Affiliation</div><div _ngcontent-ng-c3494358620="" class="details-value-less"><span _ngcontent-ng-c3494358620="">Nucleus Network</span></div></div></ctg-overall-officials-item></li><!----></ul><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Location</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><span _ngcontent-ng-c2610029805=""><ul _ngcontent-ng-c2610029805="" class="ul-adjust-margin"><li _ngcontent-ng-c2610029805=""><ctg-location-item _ngcontent-ng-c2610029805="" _nghost-ng-c2474546325=""><div _ngcontent-ng-c2474546325=""><span _ngcontent-ng-c2474546325="" class="bold-text">Saint Paul, Minnesota, United States, 55114</span></div><!----><div _ngcontent-ng-c2474546325="" class="top-margin-8px"><!----><div _ngcontent-ng-c2474546325="" class="details"><div _ngcontent-ng-c2474546325="" class="details-title-indent">Facility:</div><div _ngcontent-ng-c2474546325="" class="details-value-less"><span _ngcontent-ng-c2474546325="">Nucleus Network</span></div></div><!----><!----></div></ctg-location-item></li><!----></ul></span><!----><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----><!----></ctg-contacts-locations-card><!----><ctg-ipd-sharing-card _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="ipd-sharing-card" _nghost-ng-c2145635800=""><ctg-study-section-compare-card _ngcontent-ng-c2145635800="" title="IPD Sharing" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> IPD Sharing </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">IPD information</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><div _ngcontent-ng-c2145635800="">&nbsp;</div><!----><!----><!----><!----><!----><!----><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----></ctg-ipd-sharing-card><!----><!----><ctg-references-card _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="references-card" _nghost-ng-c4071929648=""><ctg-study-section-compare-card _ngcontent-ng-c4071929648="" title="References" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> References </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Citations</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Links</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><!----><!----><!----><!----></div><!----><!----></div><!----><div _ngcontent-ng-c1323710958="" class="cell title-cell"><div _ngcontent-ng-c1323710958="">Available IPD/Information</div></div><div _ngcontent-ng-c1323710958="" class="cell content-cell"><div _ngcontent-ng-c1323710958="" class="text-cell"><ctg-references-available-ipd-card _ngcontent-ng-c4071929648="" _nghost-ng-c2631617528=""><!----></ctg-references-available-ipd-card><!----></div><!----><!----></div><!----><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----><!----><!----></ctg-references-card><!----><ctg-study-document-card _ngcontent-ng-c2377978868="" ctgintersectionobserver="" id="document-section-card" _nghost-ng-c1905941226=""><ctg-study-section-compare-card _ngcontent-ng-c1905941226="" title="Document Section" _nghost-ng-c3664392600=""><ctg-card _ngcontent-ng-c3664392600="" _nghost-ng-c1770482603=""><h2 _ngcontent-ng-c1770482603="" role="doc-subtitle" class="card-header"> Document Section </h2><!----><div _ngcontent-ng-c1770482603="" class="card-content"><div _ngcontent-ng-c3664392600=""><ctg-study-section-fields-table _ngcontent-ng-c3664392600="" _nghost-ng-c1323710958=""><div _ngcontent-ng-c1323710958="" class="table"><!----></div></ctg-study-section-fields-table><!----><ctg-qcreview-comment-warning _ngcontent-ng-c3664392600="" class="padding-1" _nghost-ng-c513377616=""><!----></ctg-qcreview-comment-warning><!----></div></div></ctg-card></ctg-study-section-compare-card><!----></ctg-study-document-card><!----><!----><!----></div>